Levine Children's Hospital

Running trials

• Recruiting

  The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

  NCT07560826· Phase 2· Source

• Recruiting

  A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

  NCT06904261· Phase 3· Source

• Recruiting

  LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

  NCT05058508· Source

• Active, not recruiting

  Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

  NCT05782907· Phase 3· Source

• Enrolling by invitation

  EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

  NCT05610787· Source

• Active, not recruiting

  A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

  NCT05444257· Phase 3· Source

• Active, not recruiting

  Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

  NCT05206357· Phase 1· Source

• Recruiting

  Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  NCT05489887· Phase 2· Source

• Recruiting

  Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

  NCT05477563· Phase 3· Source

• Active, not recruiting

  Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

  NCT05329649· Phase 3· Source

• Recruiting

  Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  NCT05082519· Phase 2· Source

• Recruiting

  PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy

  NCT04837547· Phase 1· Source

• Recruiting

  DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  NCT04696029· Phase 2· Source

• Enrolling by invitation

  A Long-term Follow-up Study in Participants Who Received CTX001

  NCT04208529· Phase 3· Source

• Active, not recruiting

  Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  NCT04301843· Phase 2· Source

• Recruiting

  Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  NCT03587272· Phase 2· Source

• Active, not recruiting

  Neuroblastoma Maintenance Therapy Trial

  NCT02679144· Phase 2· Source

• Recruiting

  Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  NCT02559778· Phase 2· Source

• Recruiting

  A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  NCT01351545· Source

• Enrolling by invitation

  Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

  NCT01016613· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers7 recruiting
• Sickle cell disease3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Neuroblastoma2 recruiting
• Thalassaemia2 recruiting
• Acute myeloid leukemia1 recruiting
• Chronic kidney disease1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Fabry disease1 recruiting
• Heart failure1 recruiting
• Hodgkin lymphoma1 recruiting
• Multiple myeloma1 recruiting
• Obesity1 recruiting
• Sarcoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

  NCT05323734· Phase 3· Source

• Completed

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· Phase 3· Source

• Recruiting

  Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  NCT05003986· Phase 2· Source

• Recruiting

  Beat Childhood Cancer Specimen Banking and Data Registry

  NCT04715178· Source

• Completed

  Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

  NCT03263559· Phase 2· Source

• Completed

  Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

  NCT02879643· Phase 1· Source

• Completed

  Molecular-Guided Therapy for Childhood Cancer

  NCT02162732· Source

• Completed

  Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer

  NCT01802567· Source

Trial sites

• Atrium Health/Levine Children's Hospital6 trials
• Levine Children's Hospital17 trials
• Levine Children's Hospital - Hematology3 trials
• Levine Children's Hospital /ID# 2427651 trial
• Levine Children's Hospital /ID# 2501311 trial